Summit Trail Advisors’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$928K Buy
40,783
+16,267
+66% +$385K 0.01% 967
2025
Q4
$653K Sell
24,516
-8,032
-25% -$237K 0.01% 1004
2025
Q3
$988K Buy
32,548
+17,698
+119% +$537K 0.01% 841
2025
Q2
$466K Buy
+14,850
New +$491K 0.01% 757
2018
Q1
Sell
-81
Closed -$6K 796
2017
Q4
$6K Buy
+81
New +$5.45K ﹤0.01% 1356

Other funds holding ENOV

Summit Trail Advisors's ENOV Position: Q1 2026 in Review

Summit Trail Advisors increased its Enovis (ENOV) stake by 66% in Q1 2026, buying an estimated $385K and bringing the position to 40,783 shares worth $928K. The position accounts for 0.01% of the portfolio, ranked #967.

Summit Trail Advisors first reported a position in ENOV in Q4 2017 and has held it in 5 quarters since. The position peaked at $988K in Q3 2025. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.

  • Summit Trail Advisors held 40,783 shares of Enovis worth $928K as of Q1 2026.
  • Summit Trail Advisors bought 16,267 Enovis shares in Q1 2026, an estimated $385K.
  • Enovis made up 0.01% of Summit Trail Advisors's portfolio in Q1 2026, its #967 holding.
  • Summit Trail Advisors first reported a position in Enovis in Q4 2017 and has held it in 5 quarters since.
  • Summit Trail Advisors's Enovis position peaked at $988K in Q3 2025.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.